Arkolith/Insider Trading/IMGO/Form 4

Eichorn Laura G.

Chief Financial OfficerImago BioSciences, Inc. (IMGO) · full profile →Form 4 · filed Dec 29, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$111K
Net Open-Market Flow
-$111K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 27, 2022Option exercise(M)3K$2.52$8K211K
Dec 27, 2022Sell(S)3K$35.93$111K208K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 27, 2022Option exercise(M)3K—$023K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-022097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML